NCT01844986

NCT01844986 is a clinical trial studying how a specific treatment affects patients with multiple myeloma, a type of blood cancer. The study aims to evaluate whether combining certain medications improves the effectiveness of therapy, potentially leading to better outcomes. Participants receive the investigational treatment to assess its safety, side effects, and how well it works in controlling the disease. The goal is to find new, more effective options for managing multiple myeloma, ultimately improving patients' health and quality of life.